10x Genomics Stock (NASDAQ:TXG), Quotes and News Summary

Q: What sector and industry does 10x Genomics (TXG) operate in?

10x Genomics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

10x Genomics Stock (NASDAQ: TXG) stock price, news, charts, stock research, profile.

Open	$30.960
Close	$29.160
Volume / Avg.	3.063M / 1.368M
Day Range	29.120 - 31.140
52 Wk Range	30.300 - 63.570
Market Cap	$3.216B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	20
Short Interest	10.16%
Days to Cover	6.52

Recent News

Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s positive market performance on the same day. The COIN Trade

Benzinga Neuro

Gold Breaks Above $2,110, Inches Closer To Record High, With Rallying Mining Stocks

Gold prices surge on record close and mining stock rally. GLD reaches $2,110/oz, within 1.4% of all-time high.

Piero Cingari

Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About 10x Genomics Inc

Sector

Health Care

Industry

Life Sciences Tools & Services

10x Genomics Inc is a life science technology company based in the United States. Its solutions incl...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy 10x Genomics (TXG) stock?

You can purchase shares of 10x Genomics (NASDAQ: TXG) through any online brokerage.

View our list of the best stock brokerages.

Who are 10x Genomics's (TXG) competitors?

Other companies in 10x Genomics’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), Waters (NYSE:WAT), Sotera Health (NASDAQ:SHC) and Olink Holding (NASDAQ:OLK).

What is the target price for 10x Genomics (TXG) stock?

The latest price target for 10x Genomics (NASDAQ: TXG) was reported by Barclays on Wednesday, April 10, 2024. The analyst firm set a price target for 45.00 expecting TXG to rise to within 12 months (a possible 66.73% upside). 18 analyst firms have reported ratings in the last year.

Current Stock Price for 10x Genomics (TXG)?

The stock price for 10x Genomics (NASDAQ: TXG) is $26.99 last updated April 17, 2024 at 7:57 PM EDT.

Does 10x Genomics (TXG) pay a dividend?

There are no upcoming dividends for 10x Genomics.

When is 10x Genomics (NASDAQ:TXG) reporting earnings?

10x Genomics’s Q1 earnings are confirmed for Tuesday, April 30, 2024.

Is 10x Genomics (TXG) going to split?

There is no upcoming split for 10x Genomics.

What sector and industry does 10x Genomics (TXG) operate in?

10x Genomics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-